241 related articles for article (PubMed ID: 1708046)
1. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
[TBL] [Abstract][Full Text] [Related]
2. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension.
Islim IF; Bareford D; Beevers DG
Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379
[TBL] [Abstract][Full Text] [Related]
3. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.
Gupta RK; Kjeldsen SE; Krause L; Kneisley J; Posvar E; Weder AB; Julius S
Clin Pharmacol Ther; 1990 Jul; 48(1):41-9. PubMed ID: 2196144
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
[TBL] [Abstract][Full Text] [Related]
6. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Ding YA; Chang SM; Chou TC
J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
[TBL] [Abstract][Full Text] [Related]
7. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Brown NJ; Agirbasli M; Vaughan DE
Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Yaoka O; Aoki K; Nakajima T; Setoguchi M
Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
[TBL] [Abstract][Full Text] [Related]
9. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
[TBL] [Abstract][Full Text] [Related]
10. ACE inhibitor effects on platelet function in stages I-II hypertension.
Moser L; Callahan KS; Cheung AK; Stoddard GJ; Munger MA
J Cardiovasc Pharmacol; 1997 Oct; 30(4):461-7. PubMed ID: 9335405
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
Sedman AJ; Posvar E
Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
[TBL] [Abstract][Full Text] [Related]
12. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
Sánchez S; Luna A; Orozco R; Velasco G
Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Teisman AC; Pinto YM; Buikema H; Flesch M; Böhm M; Paul M; van Gilst WH
J Hypertens; 1998 Dec; 16(12 Pt 1):1759-65. PubMed ID: 9869009
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
Hausberg M; Barenbrock M; Hohage H; Müller S; Heidenreich S; Rahn KH
Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
[TBL] [Abstract][Full Text] [Related]
15. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
[TBL] [Abstract][Full Text] [Related]
16. [A comparative study of the effects of lisinopril and quinapril administered once a day in essential hypertension].
De Cesaris R; Ranieri G; Andriani A; Chiarappa R
Minerva Med; 1990; 81(7-8):541-6. PubMed ID: 2166253
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition.
London GM; Pannier B; Vicaut E; Guérin AP; Marchais SJ; Safar ME; Cuche JL
J Hypertens; 1996 Sep; 14(9):1139-46. PubMed ID: 8986916
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitors as initial monotherapy in severe hypertension. Quinapril and captopril.
Frishman WH; Greenberg S
Am J Hypertens; 1991 Oct; 4(10 Pt 1):827-31. PubMed ID: 1747216
[TBL] [Abstract][Full Text] [Related]
19. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
Kjeldsen SE; Gupta RK; Krause L; Weder AB; Julius S
Am Heart J; 1992 May; 123(5):1433-8. PubMed ID: 1575171
[TBL] [Abstract][Full Text] [Related]
20. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]